The Gut-Wrenching Effects of Cryptosporidiosis and Giardiasis in Children is a research paper published in Microorganisms (2023). On theSindex it has a DataRank of 0.500. It has been cited 27 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.500
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →United States Department of Agriculture (USDA)
Grant: 2020-67015-30881UWSC11920
United States Department of Agriculture (USDA)
Grant: R01 HD102487
United States Department of Agriculture (USDA)
Grant: R01AI089441
United States Department of Agriculture (USDA)
Grant: R21AI140881
United States Department of Agriculture (USDA)
Grant: R56AI146067
United States Department of Agriculture (USDA)
Grant: R01AI158524
United States Department of Agriculture (USDA)
Grant: R01AI111341
United States Department of Agriculture (USDA)
Grant: R01HD080670
National Institutes of Health
Grant: 5R01AI158524-04
Methionyl-tRNA Synthetase inhibitors can be developed as novel Giardiasis therapeutics
National Institutes of Health
Grant: 5R21AI140881-02
Development of Dual Efficacy Therapeutic Against Cryptosporidiosis and Giardiasis
National Institutes of Health
Grant: 1R56AI146067-01A1
Development of Cell-active Giardia lamblia Methionyl-tRNA Synthetase Inhibitors as a New Therapeutic for Giardiasis
National Institutes of Health
Grant: 5R01AI089441-05
Calcium Dependent Protein Kinase 1 as a drug target for T. gondii and C. parvum
National Institutes of Health
Grant: 5R01HD080670-05
Dual Use Therapeutics for Cryptosporidiosis, Toxoplasmosis, and Neosporosis
National Institutes of Health
Grant: 5R01HD102487-05
Bumped-Kinase Inhibitor Drug Development for Toxoplasmosis
National Institutes of Health
Grant: 5R01AI111341-04
Bumped Kinase Inhibitors: Novel Therapeutics for Cryptosporidiosis&Toxoplasmosis
FWCI
6.42
Citation Percentile
1.0%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals